Not Many Genealogical Investigations End With Stories Like This
Xulon Press presents a fascinating collection of inspirational wartime stories.
ELLICOTT CITY, Md., Sept. 23, 2024 /PRNewswire-PRWeb/ -- Author Armand Kinslow shares selected veterans' vignettes from America's founding through the Vietnam War in They Will Not Be Forgotten: One Family's Stories of Military Service From Independence to Vietnam ($14.49, paperback, 9798868502989; $6.99, e-book, 9798868502996).
Kinslow is part of an amazing line of eight generations who each served in the U.S. conflict of their era. Once he discovered this heritage, he began documenting his ancestors' stories, re-constructed from historical research and combined with his gift for storytelling, so that They Will Not Be Forgotten.
"Genealogy research uncovered fascinating and inspiring stories of family veterans that I felt had to be shared," said Kinslow.
Armand Kinslow graduated from the University of Missouri-Columbia on an NROTC scholarship and was commissioned in the USMC as an infantry officer. He later served as an intelligence officer during the Cold War, Gulf War, and Global War on Terror, retiring as a Lieutenant Colonel. Between his military and government service, Kinslow spent four decades working in intelligence gathering and analysis. He is an avid history buff, particularly of America's military campaigns.
Xulon Press, a division of Salem Media Group, is the world's largest Christian self-publisher, with more than 20,000 titles published to date. They Will Not Be Forgotten is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.
View original content:https://www.prweb.com/releases/not-many-genealogical-investigations-end-with-stories-like-this-302254877.html
SOURCE Xulon Press
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Best Graphic Design Software for Print and Production Work (2026): CorelDRAW Recognized for Print-Friendly, Production-Ready Workflows by Better Business Advice
- RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
- From Meme Coin to Trading Infrastructure: Best Crypto Presale Buyers Back AlphaPepe’s Push Beyond the Usual PEPE Copycat Model
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share